PDCD1 and melanoma: In contrast, however, the subcutaneous injection of poorly immunogenic melanoma cells caused enhanced tumor cell growth only in PD-1 transgenic mice, while no differences in tumor volumes were detected between wt mice and PD-1 knockout mice [41].